South Dakota Investment Council Incyte Corp Transaction History

South Dakota Investment Council

$5.01 Billion
Q4 2024

A detailed history of South Dakota Investment Council transactions in Incyte Corp stock. As of the latest transaction made, South Dakota Investment Council holds 170,735 shares of INCY stock, worth $12.3 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

170,735

Previous 170,735 -0.0%

Holding current value

$12.3 Million

Previous $11.3 Million 4.49%

% of portfolio

0.24%

Previous 0.22%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $56,349 - $70,188	-1,101 Reduced 0.64%	170,735 $10.4 Million
Q4 2023 Feb 01, 2024	SELL	$52.16 - $64.19 $271,232 - $333,788	-5,200 Reduced 2.94%	171,836 $10.8 Million
Q3 2023 Nov 07, 2023	SELL	$57.77 - $65.93 $742,228 - $847,068	-12,848 Reduced 6.77%	177,036 $10.2 Million
Q2 2023 Aug 10, 2023	SELL	$60.95 - $75.51 $731,400 - $906,120	-12,000 Reduced 5.94%	189,884 $11.8 Million
Q1 2023 May 10, 2023	BUY	$70.23 - $86.01 $709,323 - $868,701	10,100 Added 5.27%	201,884 $14.6 Million
Q4 2022 Feb 07, 2023	SELL	$67.18 - $84.11 $423,234 - $529,893	-6,300 Reduced 3.18%	191,784 $15.4 Million
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $14,824 - $18,632	-224 Reduced 0.11%	198,084 $15 Million
Q1 2022 May 10, 2022	SELL	$66.02 - $79.71 $3.25 Million - $3.92 Million	-49,172 Reduced 19.87%	198,308 $15.8 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $13.8 Million - $16.1 Million	217,580 Added 727.69%	247,480 $18.2 Million
Q3 2021 Nov 09, 2021	BUY	$68.67 - $84.02 $2.05 Million - $2.51 Million	29,900 New	29,900 $2.06 Million
Q3 2020 Nov 06, 2020	SELL	$85.07 - $109.69 $187,153 - $241,318	-2,200 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$63.18 - $85.97 $138,996 - $189,134	2,200 New	2,200 $161,000

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council Incyte Corp Transaction History